Intuitive Surgical, Inc.

Equities

ISRG

US46120E6023

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 04:00:00 2023-12-08 pm EST			5-day change	1st Jan Change
310.42 ^USD	-0.37%		-1.52%	+16.99%

Dec. 04	Morgan Stanley Raises Intuitive Surgical Price Target to $330 From $300, Maintains Equal Weight Rating	MT
Nov. 21	It’s Nvidia Day

Capstan Medical Inc. announced that it has received $31.4 million in funding from Intuitive Surgical, Inc., Eclipse Ventures, LLC, Puma Venture Capital

August 08, 2023

On August 9, 2023, Capstan Medical closed the transaction. The company received $31,400,000 in a round of funding led by new investor Eclipse Ventures, LLC. The transaction included participation from new investors Intuitive Surgical, Inc., Puma Venture Capital.

Justin Butler of Eclipse joins board of director of the company. This funding round was over-subscribed.

Latest news about Intuitive Surgical, Inc.

Morgan Stanley Raises Intuitive Surgical Price Target to $330 From $300, Maintains Equal Weight Rating	Dec. 04	MT
It’s Nvidia Day	Nov. 21
ANALYST RECOMMENDATIONS : Ashtead, Crowdstrike, Hershey, Ulta Beaty, Zoom...	Nov. 21
Intuitive Surgical Insider Sold Shares Worth $2,870,100, According to a Recent SEC Filing	Nov. 17	MT
Intuitive Surgical Insider Sold Shares Worth $2,645,700, According to a Recent SEC Filing	Nov. 17	MT
Investors see life through rose-colored glasses	Nov. 17
ANALYST RECOMMENDATIONS : Air Products & Chemicals, Barclays, Glencore, Mastercard, Walmart...	Nov. 17
Intuitive Surgical Insider Sold Shares Worth $251,430, According to a Recent SEC Filing	Nov. 16	MT
Corporate America weighs business impact of new weight-loss drugs	Nov. 13	RE
Corporate America weighs business impact of new weight-loss drugs	Nov. 08	RE
Johnson & Johnson to submit application to start trials for surgical robot	Nov. 07	RE
Intuitive Surgical, Inc. Appoints Sreelakshmi Kolli to Its Board of Directors	Oct. 31	CI
Argus Research Adjusts Intuitive Surgical Price Target to $310 From $365, Maintains Buy Rating	Oct. 31	MT
Analysis-Healthcare companies counter investor worries over Wegovy effect	Oct. 27	RE
Corporate America weighs business impact of new weight-loss drugs	Oct. 26	RE
Intuitive Surgical Insider Sold Shares Worth $303,574, According to a Recent SEC Filing	Oct. 25	MT
Morgan Stanley Cuts Intuitive Surgical's Price Target to $300 From $330, Keeps Equalweight Rating	Oct. 23	MT
Health Care Drops as Obesity-Drug Potential Weighs on Intuitive -- Health Care Roundup	Oct. 20	DJ
Deutsche Bank Adjusts Intuitive Surgical Price Target to $275 From $335, Maintains Hold Rating	Oct. 20	MT
Global markets live: L'Oreal, Hewlett Packard Enterprise, American Express, Pfizer, Toyota...	Oct. 20
Wells Fargo Cuts Price Target on Intuitive Surgical to $363 From $386, Maintains Overweight Rating	Oct. 20	MT
Medical device makers see limited hit from weight-loss drugs	Oct. 20	RE
UBS Adjusts Intuitive Surgical Price Target to $316 From $314, Maintains Neutral Rating	Oct. 20	MT
Sector Update: Health Care	Oct. 20	MT
Sector Update: Health Care Stocks Mixed Premarket Friday	Oct. 20	MT

Chart Intuitive Surgical, Inc.

Duration

Period

More charts

Company Profile

Intuitive Surgical, Inc. specializes in the design, manufacturing, and marketing of robotic surgical assistance video systems. The systems consist of a surgical console, arm, remote-controlled endoscope, and 3D visual immersion system. Net sales break down by activity as follows: - sale of instruments and accessories (56.5%): primarily wrist cuffs; - sale of robotic systems (27%): systems marketed under the da Vinci brand (1,264 units sold in 2022) and intended primarily for urological, cardio-thoracic, and gynecological surgeries; - installation and training services (16.5%). The United States accounts for 66.8% of net sales.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-01-24 - Q4 2023 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Intuitive Surgical, Inc.

Trading Rating :

Investor Rating :

ESG Refinitiv :

B-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

310.42USD

Average target price

327.83USD

Spread / Average Target

+5.61%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
INTUITIVE SURGICAL, INC.	+16.99%	109 B $
THERMO FISHER SCIENTIFIC	-11.06%	189 B $
DANAHER CORPORATION	-18.06%	161 B $
BOSTON SCIENTIFIC CORPORATION	+18.76%	80 501 M $
SIEMENS HEALTHINEERS AG	+12.86%	63 269 M $
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-6.32%	49 971 M $
EDWARDS LIFESCIENCES CORPORATION	-7.28%	41 958 M $
AGILENT TECHNOLOGIES, INC.	-15.00%	37 158 M $
GE HEALTHCARE TECHNOLOGIES INC.	+17.37%	31 193 M $
RESMED, INC.	-21.75%	23 955 M $

Other Advanced Medical Equipment & Technology